HA
AGN

Havens Advisors’s Allergan plc AGN Stock Holding History

Havens Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-72,074
Closed -$12.8M – 29
2020
Q1 		$12.8M Buy
72,074
+574
+0.8% +$108K 12.44% 1
2019
Q4 		$13.7M Buy
71,500
+13,000
+22% +$2.35M 11.99% 1
2019
Q3 		$9.85M Buy
58,500
+32,500
+125% +$5.29M 8.96% 2
2019
Q2 		$4.35M Buy
+26,000
New +$3.6M 3.06% 12

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Havens Advisors's AGN Position: Q2 2020 in Review

Havens Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 72,074 shares — an estimated $12.8M sold.

Havens Advisors first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $13.7M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Havens Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Havens Advisors sold 72,074 Allergan plc shares in Q2 2020, an estimated $12.8M.
  • Havens Advisors first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Havens Advisors's Allergan plc position peaked at $13.7M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Havens Advisors's 13F filing for Q2 2020, filed 24 Jul 2020.